| PubMed |
Abstract |
RScore(About this table) |
| 19653131 |
Oien DB, Shinogle HE, Moore DS, Moskovitz J: Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells. J Mol Neurosci. 2009 Nov;39(3):323-32. Epub 2009 Aug 4.
|
6(0,0,0,6) |
Details |
| 17504092 |
Kim S, Kang M, Ryu Y, Kim TD: A short C-terminal region of alpha-synuclein protects a (R/S)-non-specific esterase from Archaeglobus fulgidus. Protein Pept Lett. 2007;14(4):347-51.
|
3(0,0,0,3) |
Details |
| 18239841 |
Kowalik-Jankowska T, Rajewska A, Jankowska E, Grzonka Z: Products of Cu (II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide. Dalton Trans. 2008 Feb 14;(6):832-8. Epub 2007 Dec 4.
|
2(0,0,0,2) |
Details |
| 18032652 |
Wassef R, Haenold R, Hansel A, Brot N, Heinemann SH, Hoshi T: Methionine sulfoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson's-like symptoms. J Neurosci. 2007 Nov 21;27(47):12808-16.
Here, we show that one member of the MSR family, MSRA, inhibits development of the locomotor and circadian rhythm defects caused by ectopic expression of human alpha-synuclein in the Drosophila nervous system. |
2(0,0,0,2) |
Details |
| 20064662 |
Lucas HR, Lee JC: Effect of dioxygen on copper (II) binding to alpha-synuclein. . J Inorg Biochem. 2010 Mar;104(3):245-9. Epub 2009 Dec 23.
|
2(0,0,0,2) |
Details |
| 18456002 |
Liu F, Hindupur J, Nguyen JL, Ruf KJ, Zhu J, Schieler JL, Bonham CC, Wood KV, Davisson VJ, Rochet JC: Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults. Free Radic Biol Med. 2008 Aug 1;45(3):242-55. Epub 2008 Apr 11.
PD pathogenesis involves mitochondrial dysfunction, proteasome impairment, and alpha-synuclein aggregation, insults that may be especially toxic to oxidatively stressed cells including dopaminergic neurons. |
2(0,0,0,2) |
Details |